A Hidden Danger in the Eye
Imagine a doctor looking into your eye with a bright light, searching for a dangerous infection. They might miss a small pocket of pus hiding behind your iris. That delay could cost you your sight.
Now, imagine a high-resolution scan that sees that hidden pus clearly, every time.
That’s what a new study suggests. Researchers compared a standard eye exam with a newer imaging tool called anterior segment optical coherence tomography (ASOCT). The scan spotted signs of infection that the traditional exam missed.
Microbial keratitis is a serious infection of the cornea—the clear front window of the eye. It can be caused by bacteria, fungi, or parasites. If not treated quickly, it can lead to permanent vision loss or even blindness.
One key sign of a severe infection is a hypopyon—a layer of pus that settles at the bottom of the eye’s front chamber. Detecting it early helps doctors decide how aggressively to treat the infection.
The standard tool for this is the slit lamp—a microscope with a bright light. But it’s not perfect. The hypopyon can be small or hidden behind the iris, making it easy to miss.
The Old Way vs. The New Way
For decades, slit lamp examination (SLE) has been the gold standard. Doctors rely on their eyes and experience to spot a hypopyon.
But here’s the twist: a study published in medRxiv in April 2026 shows that ASOCT—a high-resolution scan—detects hypopyon more often than the slit lamp.
ASOCT uses light waves to create detailed cross-section images of the eye’s front structures. It’s non-invasive, quick, and doesn’t require contact with the eye.
Think of the eye’s front chamber like a small room. A hypopyon is like a layer of dust settling on the floor. The slit lamp is like looking through a window with a flashlight—you might see the dust if it’s thick enough, but you could miss a thin layer.
ASOCT is like having a laser scanner that maps the entire room in 3D. It can detect even a thin layer of dust on the floor.
In eye terms, ASOCT creates detailed images of the space between the cornea and the iris. It can measure the height of the hypopyon and its exact location, giving doctors precise data.
Researchers analyzed images from eyes with confirmed microbial keratitis. Two trained graders independently reviewed ASOCT images to detect hypopyon. They also measured the hypopyon’s height using two methods: endothelial length and vertical height.
The study compared these findings with slit lamp exams done by experienced ophthalmologists.
ASOCT detected hypopyon in 67.1% of eyes, while slit lamp exams found it in only 57.0%. That’s a significant difference—especially for patients with smaller or hidden infections.
When ASOCT was used as the reference standard, it showed 83% sensitivity and 96% specificity. That means it correctly identified most true cases and rarely gave false alarms.
Inter-grader agreement was excellent. Two different graders looking at the same ASOCT images agreed almost perfectly on whether a hypopyon was present.
Intra-grader reproducibility was also excellent. When the same grader measured the hypopyon height multiple times, the results were consistent.
For measuring hypopyon height, endothelial length showed slightly better agreement between graders than vertical height.
But there’s a catch.
This study shows ASOCT is a powerful tool for detecting hypopyon, especially when the slit lamp exam is inconclusive. It offers objective, reproducible measurements that can help guide treatment.
This doesn’t mean this treatment is available yet.
ASOCT is already used in some specialty eye clinics, but it’s not standard in all hospitals. More research is needed to confirm these findings in larger, more diverse patient groups.
If you have a serious eye infection, your doctor may already use ASOCT if it’s available. Ask if your clinic has this technology. It could provide a clearer picture of your infection and help tailor your treatment.
But ASOCT is not a replacement for slit lamp exams. It’s a complementary tool that adds precision.
This study was small and focused on a specific type of eye infection. The findings need to be confirmed in larger trials. Also, ASOCT requires specialized equipment and trained staff, which may not be available everywhere.
Researchers hope to expand this work to larger patient groups and other types of eye infections. If confirmed, ASOCT could become a standard part of diagnosing microbial keratitis, helping more patients get the right treatment faster.
The next step is more research—and wider access to this promising technology.